Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.7.49 (
reverse transcriptase
)
31,746
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The dehydrogenase/reductase (SDR family) member 4 (
DHRS4
) gene is copied during mammalian evolution; therefore, while only one
DHRS4
gene is expressed in the mouse genome, the gene cluster consists of two (
DHRS4
and DHRS4L1) and three (
DHRS4
, DHRS4L2, and DHRS4L1) copies in chimpanzees and humans, respectively. In this study, we explored the possible regulatory mechanism of the
DHRS4
gene cluster in mammalian evolution by analyzing the promoter sequence, methylation of CpG islands, and RNA expression of the
DHRS4
gene cluster in mice, chimpanzees, and humans by bioinformatics prediction, bisulfite sequencing PCR, and real-time
reverse transcriptase
-PCR. The results indicated that the
DHRS4
gene was actively expressed in the three model species. The RNA level of DHRS4L1 was much lower than those of
DHRS4
and DHRS4L2, and expressed lower homologous sequence identity to
DHRS4
and DHRS4L2. DHRS4L2, the latest evolutionary copy of the
DHRS4
gene in mammals, received a high promoter prediction score, and was the only copy of the
DHRS4
gene cluster presenting hypermethylated CpG islands in the promoter region. An analysis of the relationship between the promoter characteristics and RNA expression of the
DHRS4
gene cluster indicated that the development of CpG islands, in addition to the promoter sequence, during mammalian evolution could modulate the dose compensatory regulation of the copy number-varied
DHRS4
gene cluster.
...
PMID:CpG island evolution in the mammalian DHRS4 gene cluster and its role in the regulation of gene transcription. 2732 17